logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5915.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5915.produseast1
Covid-19 in humanitarian settings—modelling, measuring & applying lessons (MSF Scientific Days International 2022) | Collections | MSF Science Portal
Covid-19 in humanitarian settings—modelling, measuring & applying lessons (MSF Scientific Days International 2022)

Covid-19 in humanitarian settings—modelling, measuring & applying lessons (MSF Scientific Days International 2022)

Collection Content

Download Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.

  • All Assets (12)
  • CSV
  • BibTeX
  • EndNote
Download Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.

  • All Assets (12)
  • CSV
  • BibTeX
  • EndNote

See more collections

MSF logo

International Women's Day 2023
No description available
Neglected tropical diseases

Neglected tropical diseases

Each year hundreds of thousands of people die from a neglected tropical disease, while many more suffer serious illness or lifelong disability. Yet as we mark World Neglected Tropical Diseases (NTD) Day on 30th January, global progress towards eliminating these diseases is threatened by shifting global health priorities and declining investment in the wake of the Covid-19 pandemic.


The content collection linked below offers a snapshot of MSF’s work on managing some of the most deadly NTDs, finding better tools and models of care for highly affected populations, and advocating for greater access to care and increased global funding. Several authors describe our programs and lessons learned from a decade of treating snakebite victims in sub-Saharan Africa. Two studies evaluate shorter, less toxic treatment for visceral leischmaniasis, while a policy analysis proposes critical steps towards eliminating this horrific disease in East Africa. Last, reports from Sokoto, Nigeria describe the collaborative development of a comprehensive model of care for noma.

TB-PRACTECAL Trial—Evidence for a shorter, safer, more effective treatment for drug-resistant tuberculosis

TB-PRACTECAL Trial—Evidence for a shorter, safer, more effect...
View All Collections
Drug-resistant tuberculosis (DR-TB) remains an especially deadly form of the ancient scourge of TB, while current treatments are long, toxic, and ineffective for half of all patients. Aiming to change this unacceptable status quo, in the mid-2010’s MSF and partners launched three clinical trials to test novel regimens containing the first new TB drugs in decades. On 22 December 2022 the New England Journal of Medicine published findings from TB-PRACTECAL, a three-country randomized controlled trial, showing that a shorter regimen is safer and cured 89% of DR-TB patients, compared with 52% on the standard of care. These findings have already been incorporated into the World Health Organization’s new TB treatment guidelines. A separate study shows that the new regimen is also more cost-effective. Alongside these results the content collection linked below highlights other aspects of the trial, from community engagement strategies that helped shape TB-PRACTECAL to setbacks arising from the Covid-19 pandemic. It also examines urgent challenges in scaling up access to these life-saving drugs, including affordability and patent barriers.
Conference Material
|
Video

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Conference Material
|
Video

Face mask acceptability and usage after mass distribution in a refugee camp during the Covid-19 pandemic: mixed-methods study

Sadique S
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Conference Material
|
Video

Facilitating safe discharge through predicting disease progression in moderate Covid-19: development and validation of a prediction model in resource-limited settings

Chandna A
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Conference Material
|
Video

Retrospective mortality and prevalence of SARS-CoV-2 antibodies in greater Omdurman, Sudan: a population–based cross–sectional survey

Moser W
2022-06-07 • MSF Scientific Days International 2022
2022-06-07 • MSF Scientific Days International 2022
Conference Material
|
Slide Presentation

Face mask acceptability and usage after mass distribution in a refugee camp during the Covid-19 pandemic: mixed-methods study

Sadique S, Lin YD, Walker SA, Rao B, du Cros PAK,  et al.
2022-05-10 • MSF Scientific Days International 2022
2022-05-10 • MSF Scientific Days International 2022
Conference Material
|
Slide Presentation

Facilitating safe discharge through predicting disease progression in moderate Covid-19: development and validation of a prediction model in resource-limited settings

Chandna A, PRIORITISE Study Group, Mahajan R, Gautam P, Mwandigha L,  et al.
2022-05-10 • MSF Scientific Days International 2022
2022-05-10 • MSF Scientific Days International 2022
Conference Material
|
Slide Presentation

Retrospective mortality and prevalence of SARS-CoV-2 antibodies in greater Omdurman, Sudan: population–based cross–sectional survey

Moser W, Hassan Fahal MA, Abualas E, Bedri S, Elsir MT,  et al.
2022-05-10 • MSF Scientific Days International 2022
2022-05-10 • MSF Scientific Days International 2022
Conference Material
|
Abstract

Retrospective mortality and prevalence of SARS-CoV-2 antibodies in greater Omdurman, Sudan: population–based cross–sectional survey

Moser W, Hassan Fahal MA, Abualas E, Bedri S, Elsir MT,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
In Sudan, since the first Covid-19 case was declared on 13 March 2020, 32,846 confirmed cases were recorded through 10 April 2021. Of these, 72% were registered in Khart...
Conference Material
|
Abstract

Face mask acceptability and usage after mass distribution in a refugee camp during the Covid-19 pandemic: mixed-methods study

Sadique S, Lin YD, Walker SA, Rao B, du Cros PAK,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
The crowded conditions within camps for refugees and internally displaced people create risk environments for unmitigated transmission of SARS-CoV-2. Within one such set...
Conference Material
|
Abstract

Facilitating safe discharge through predicting disease progression in moderate COVID-19: development and validation of a prediction model in resource-limited settings

Chandna A, PRIORITISE Study Group, Mahajan R, Gautam P, Mwandigha L,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
In locations where few people have received Covid-19 vaccines, health systems remain vulnerable to spikes in SARS-CoV-2 infections. Triage tools, which could include bio...
Conference Material
|
Abstract

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA, Puig-García M, Silver C, Pearlman J, Stellmach DUS,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022
INTRODUCTION
Between 2020 and 2021, MSF’s social sciences team designed and supported implementation of qualitative assessments to better understand community-level outbreak response...
Conference Material
|
Slide Presentation

A multi-site synthesis on health and wellbeing during the Covid-19 pandemic: findings from seven countries

Croft LA, Puig-García M, Silver C, Pearlman J, Stellmach DUS,  et al.
2022-05-09 • MSF Scientific Days International 2022
2022-05-09 • MSF Scientific Days International 2022